AGI

Serial Number 75112428
Registration 2388033
900

Registration Progress

Application Filed
May 31, 1996
Under Examination
Apr 15, 1997
Approved for Publication
Dec 20, 1996
Published for Opposition
Jan 21, 1997
Registered
Sep 19, 2000

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: AGI
Previous Owner: AtheroGenics, Inc.

Trademark Image

AGI

Basic Information

Serial Number
75112428
Registration Number
2388033
Filing Date
May 31, 1996
Registration Date
September 19, 2000
Published for Opposition
January 21, 1997
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
900
Status Date
Jun 27, 2014

Rights Holder

AtheroGenics, Inc.

03
Address
3065 Northwoods Circle
Norcross, GA 30071

Ownership History

AtheroGenics, Inc.

Original Applicant
03
Norcross, GA

AtheroGenics, Inc.

Owner at Publication
03
Norcross, GA

AtheroGenics, Inc.

Original Registrant
03
Norcross, GA

Legal Representation

Attorney
FRANK S. BENJAMIN

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

30 events
Date Code Type Description Documents
Jun 27, 2014 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Loading...
Dec 27, 2006 CFIT O CASE FILE IN TICRS Loading...
Nov 21, 2006 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 16, 2006 PLGL A ASSIGNED TO PARALEGAL Loading...
Sep 19, 2006 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Oct 2, 2006 CANT T CANCELLATION TERMINATED NO. 999999 Loading...
Oct 2, 2006 CAND T CANCELLATION DENIED NO. 999999 Loading...
Sep 19, 2006 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 29, 2004 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Jan 30, 2002 PETC T CANCELLATION INSTITUTED NO. 999999 Loading...
Sep 19, 2000 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 8, 2000 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 8, 2000 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 4, 2000 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 13, 2000 IUAF S USE AMENDMENT FILED Loading...
Nov 1, 1999 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 12, 1999 EXT5 S SOU EXTENSION 5 FILED Loading...
May 10, 1999 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 13, 1999 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 6, 1998 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 14, 1998 EXT3 S SOU EXTENSION 3 FILED Loading...
May 29, 1998 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 15, 1998 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 12, 1997 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 15, 1997 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 15, 1997 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 1997 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 20, 1996 NPUB O NOTICE OF PUBLICATION Loading...
Nov 4, 1996 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 25, 1996 DOCK D ASSIGNED TO EXAMINER Loading...

Additional Information

Other
In the statement, Column 1, lines 4 - Column 2, line 4, are deleted, and, MEDICAL DIAGNOSTIC AND PRESCRIPTION PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF RHEUMATOID AND PULMONARY INFLAMMATORY AND CARDIOVASCULAR DISEASES, NAMELY, ANGINA, ASTHMA, ATHEROSCLEROSIS, CORONARY ARTERY DISEASES, ISCHEMIA, POST-ANGIOPLASTY RESTENOSIS, PROLIFERATIVE DISORDERS OF SMOOTH MUSCLE CELLS AND RHEUMATOID ARTHRITIS is inserted.